ULURU Inc. (ULU) to Present Commercial Exhibit and Clinical Data on Altrazeal at Top Clinical Wound Care Industry Symposium
ULURU, Inc., www.uluruinc.com – the pharmaceutical developer that specializes in unique products for wound closure and oral care based on a suite of constantly evolving proprietary technology that generally features strong nanoparticle science, reported today that the Company will host a commercial exhibit and also present scientific data at the Symposium on Advances in Skin and Wound Care and Wound Healing Society (Apr. 14-17) in Dallas, Texas. This massive symposium is in its 24th year and is easily the most important seasonal event in the clinical wound care field, drawing in over 2k researchers and medical professionals from across the…